Literature DB >> 25548444

Micro-organisms Associated with Febrile Neutropenia in Patients with Haematological Malignancies in a Tertiary Care Hospital in Eastern India.

Prakas Kumar Mandal1, Suman Kumar Maji2, Tuphan Kanti Dolai1, Rajib De1, Shyamali Dutta1, Sandeep Saha1, Maitreyee Bhattacharyya1.   

Abstract

There is paucity of information from eastern India with regard to observed dominant micro-organisms causing febrile neutropenia (FN) in patients with haematological malignancies. To identify the prevalence of pathogenic microorganisms associated with FN. A total number of 268 episodes of FN were analysed from September'2010 to October'2013. The blood samples were inoculated into brain heart infusion broth, glucose broth, Hicombi dual performance media (Himedia, LQ-12) at 37° C for 168 h and Bactec method was also performed for these samples. Blood agar, chocolate agar, MacConkey's agar and cystine lactose electrolyte deficient agar were used for isolation of the microorganisms. A total number of 78 (29.10 %) episodes revealed positive growths. Gram negative bacilli and Gram positive cocci were isolated in 61.53 and 34.61 % cases respectively. The eight commonest isolates were Pseudomonas aeruginosa (14.10 %), methicillin resistant Staphylococcus aureus (MRSA-12.82 %), Acinetobacter sps (11.53 %), coagulase negative Staphylococcus (10.25 %), Klebsiella pneumoniae (8.97 %), Escherichia coli (8.97 %), ESBL E. coli (6.41 %), methicillin sensitive S. aureus (MSSA-6.41 %). Amongst other less common isolates were Citrobacter kosseri (3.84 %), Citrobacter freundii (2.56 %), Ralstonia paucula (2.56 %), Cedecia neteri (1.28 %), methicillin resistant coagulase negative Staphylococcus (2.56 %). Candida spp. including two cases of Candida non-albicans was isolated in 3.84 % of cases. P. aeruginosa was the commonest pathogenic isolates in FN patients associated with haematological malignancies in this study. Gram negative bacteria were the commonest isolates in FN including significant numbers of rare opportunistic micro-organisms.

Entities:  

Keywords:  Blood stream infection; Febrile neutropenia; Gram negative organisms

Year:  2014        PMID: 25548444      PMCID: PMC4275510          DOI: 10.1007/s12288-014-0393-1

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  22 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

2.  Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program.

Authors:  A Cometta; T Calandra; H Gaya; S H Zinner; R de Bock; A Del Favero; G Bucaneve; F Crokaert; W V Kern; J Klastersky; I Langenaeken; A Micozzi; A Padmos; M Paesmans; C Viscoli; M P Glauser
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

3.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

Authors:  G P Bodey; M Buckley; Y S Sathe; E J Freireich
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

Review 4.  Infectious complications during autotransplantation.

Authors:  E C Reed
Journal:  Hematol Oncol Clin North Am       Date:  1993-06       Impact factor: 3.722

5.  Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia.

Authors:  T A Madani
Journal:  Infection       Date:  2000 Nov-Dec       Impact factor: 3.553

6.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

7.  Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials.

Authors:  L S Elting; E B Rubenstein; K V Rolston; G P Bodey
Journal:  Clin Infect Dis       Date:  1997-08       Impact factor: 9.079

8.  Emergence of multidrug resistant acinetobacter blood stream infections in febrile neutropenia patients with haematological cancers and bone marrow failure syndromes.

Authors:  Prashant Sood; Tulika Seth; Arti Kapil; Vandana Sharma; Aniruddha Dayama; Sanjeev Sharma; Suman Kumar; Avinash K Singh; Pravas Mishra; Manoranjan Mahapatra
Journal:  J Indian Med Assoc       Date:  2012-07

9.  Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases.

Authors:  W Kern; E Kurrle; T Schmeiser
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

10.  Review of clinical profile and bacterial spectrum and sensitivity patterns of pathogens in febrile neutropenic patients in hematological malignancies: A retrospective analysis from a single center.

Authors:  Arun B Karanwal; Bharat J Parikh; Parijat Goswami; Harsha P Panchal; Bhavesh B Parekh; Kaushal B Patel
Journal:  Indian J Med Paediatr Oncol       Date:  2013-04
View more
  6 in total

1.  Pattern of Antimicrobial Sensitivity in Microbiologically Documented Infections in Neutropenic Patients with Haematological Malignancies: A single Center Study.

Authors:  Aisha Jamal; Naveena Fatima; Sajjad Shaikh; Bushra Kaleem; Qurratul Ain Rizvi; Uzma Zaidi; Munira Borhany; Tahir Shamsi
Journal:  Indian J Microbiol       Date:  2019-03-04       Impact factor: 2.461

Review 2.  Rapid Fire: Infectious Disease Emergencies in Patients with Cancer.

Authors:  Stephanie Charshafian; Stephen Y Liang
Journal:  Emerg Med Clin North Am       Date:  2018-06-11       Impact factor: 2.264

3.  Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia.

Authors:  M Ponraj; Biswajit Dubashi; B H Harish; S Kayal; S L Cyriac; Jogamaya Pattnaik; K Ranjith; Unni S Pillai; Naresh Jadhav; Kiran K Matta; Jagdeep Singh; Esha Jaffa; Bhanu Prakash
Journal:  Support Care Cancer       Date:  2018-05-17       Impact factor: 3.603

4.  Analysis of blood stream infections, antibiograms and clinical outcomes in haematological patients with febrile neutropenia: data from a tertiary care haematology institute in India.

Authors:  Shouriyo Ghosh; Mandira Chakraborty; Sambit Samanta; Nilanjan Sinha; Sandeep Saha; Arnab Chattopadhyay; Siddhartha Sankar Roy; Maitreyee Bhattacharyya
Journal:  Ann Hematol       Date:  2020-11-02       Impact factor: 3.673

5.  Outbreak of Burkholderia Cepacia Infection: a Systematic Study in a Hematolooncology Unit of a Tertiary Care Hospital from Eastern India.

Authors:  Shuvra Neel Baul; Rajib De; Prakas Kumar Mandal; Swagnik Roy; Tuphan Kanti Dolai; Prantar Chakrabarti
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-09-01       Impact factor: 2.576

6.  An Unusual Cause of Neutropenic Fever: Spontaneous Pantoea agglomerans Bacteremia in an Adult.

Authors:  Victoria Zaccone; Mary Lockwood; Javier Ticona; Pedram Jouharian; Michelle Zamora; Christopher Hampton; Baho Sidiqi; Samir Kumar; Isabel M McFarlane
Journal:  Am J Med Case Rep       Date:  2020-06-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.